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Introduction: GRNDaD is a prospective registry for people with SCD that opened to enrollment 
in 2016. Nine comprehensive SCD centers from across the United States are currently enrolling 
patients. The registry includes iron status and management data, important in SCD because 
chronic transfusion therapy is a mainstay of prophylactic management. Each unit of transfused 
blood introduces approximately 250 mg of iron into the blood, which can lead to systemic iron 
deposition, and untreated may lead to organ dysfunction or death. 
Methods: GRNDaD currently contains prospective baseline and annual update information on 
approximately 1000 people with SCD. We analyzed ferritin levels relative to genotype, age, 
gender, treatment type, liver iron scan results, and chelation therapy history, using chi-squared 
and pearson statistics for discrete and continuous data, respectively. 
Results: There were 783 adults in GRNDaD who had a non-crisis ferritin level from a routine 
follow-up visit. Nearly 1 in 3 of all participants (n=187, 31.4%) had a baseline ferritin ≥1500 
mg/dL. More than a third of that group were not on chelation, and only a quarter had imaging 
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studies to assess iron accumulation. Ferritin levels were positively associated with liver 
enzymes, creatinine, and homozygous SCD phenotype. 
Conclusion: A significant fraction of the adult SCD population in GRNDaD is living with iron 
overload, and management could use vast improvement. We speculate that undertreated iron 
overload is probably both widespread and under-recognized. We anticipate that GRNDaD may 
be a model for identifying and addressing deficiencies in current clinical practices for 
management of SCD. 
